drugset / Trial / NCT03024502

Patients With Vulvovaginal Candidiasis

NCT03024502

Phase 1/2 Unknown 90 enrolled University of Sao Paulo
RandomizedParallel-groupOpen-labelTreatment

Summary

The present study aims to evaluate the safety of two mucoadhesive gels containing a propolis standardized extract identified as EPP-AF, with 1 and 2% of propolis. The efficacy studies with both propolis gels will be performed in comparison with clotrimazole cream in patients presenting vulvovaginal candidiasis.

Timeline

Start
2018-01-30
Primary completion
2020-01
Completion
2020-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Clotrimazole Unknown Other
Subject EPP-AF Unknown 1 % Other
Subject EPP-AF Unknown 2 % Other